Founder and Chief Executive Officer
Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.
Vice President Research and Regulatory Affairs
Dr. Sand recently joined the company to support on-going commercialization efforts, as well as initiate an active research program to advance the company’s technology platform.